Description
NCCN Clinical Practice Guidelines in Oncology Breast Cancer (PDF: 748K)
Dates and Times
End Date: 3/27/2012
Objectives
Upon completion of this educational activity, the participant should be able to: 1.) Review the indications for prescribing bisphosphonates for bone loss in women with breast cancer. 2.) Review the anit-tumor effects of Bisphophonates in the adjuvant setting.Webcasts Files
File | Link |
---|---|
PDF of Slides |
Download |
Accreditation
The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians
The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.